Log in
Enquire now
Tune Therapeutics

Tune Therapeutics

Tune Therapeutics is a company founded by Akira Matsuno.

OverviewStructured DataIssuesContributors

Contents

tunetx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Drug discovery
Drug discovery
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Seattle
Seattle
0
Durham, North Carolina
Durham, North Carolina
0
Founder
‌
Akira Matsuno
0
Pitchbook URL
pitchbook.com/profiles...482022-46
Email Address
careers@tunetx.com0
media@tunetx.com0
partners@tunetx.com0
Full Address
701W. Main St., Durham, North Carolina 27701, United States0
1616 Eastlake Ave E, Seattle, Washington 98102, United States0
Investors
‌
Hevolution
Yosemite
Yosemite
‌
Regeneron Ventures
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
Hatteras Venture Partners
Hatteras Venture Partners
Emerson Collective
Emerson Collective
Mission BioCapital
Mission BioCapital
Total Funding Amount (USD)
215,000,000
40,000,000
Latest Funding Round Date
January 13, 2025
December 2, 2021
Latest Funding Type
Series A
Series A

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
40,000,000
175,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Tune Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.